Skip to content

Effect of exercise on diabetic peripheral neuropathy.

Effect of aerobic training on neural conduction and glucose control in type-2 diabetic men with peripheral neuropathy.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017012032066N1
Enrollment
32
Registered
2017-03-09
Start date
2015-06-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Polyneuropathy. Diabetic polyneuropathy (E10-E14 with common fourth character .4+)

Interventions

Intervention 1: Control group: Without exercise intervention. Throughout the study period control group were asked to continue habitual physical activity. Intervention 2: Intervention group: aerobic e
Lifestyle
Control group: Without exercise intervention. Throughout the study period control group were asked to continue habitual physical activity.
Intervention group: aerobic exercise training including walking or running for 20 to 45 minutes at the intensity of 50% to 70% of heart rate reserve, 3 days a week, through 12 weeks.

Sponsors

Investigator
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: being at the age of 30 to 60 years; type 2 diabetes; diabetes history for over 5 years; HbA1C more than 6.6%; diagnosed by a physician; abnormal electrodiagnostic examination confirming peripheral neuropathy. Exclusion criteria: type-1 diabetes; insulin therapy; exercising regularly and having a restriction for exercise participation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nerve conduction velocity. Timepoint: Before and after the intervention. Method of measurement: Using EMG system; in terms of meter/second.

Secondary

MeasureTime frame
Plasma glucose. Timepoint: Before and after intervention. Method of measurement: Using specific kit; in terms of miligram/desiliter.;Lipid profile. Timepoint: Before and after intervention. Method of measurement: Using specific kit; in terms of miligram/desiliter.;Glycosylated hemoglobin (HbA1c). Timepoint: Before and after intervention. Method of measurement: Using specific kit; in terms of percent.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Gholami

Shahrood University of Technology

gholami-fa@shahroout.ac.ir; gholami.farhaad@gmail.com+98 23 3239 5900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026